Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Clinical trial NCT00003380 · TERMINATED

Trial details

NCT number: NCT00003380
Sponsor: Gynecologic Oncology Group
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1998-05-01
Primary completion: 2002-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.